Peroxisome proliferator-activated receptor (PPAR) γ agonists, thiazolidinediones, are used for the treatment of type 2 diabetes [13], and PPARα agonists belonging to the fibrate class of compounds are used for the treatment of dyslipidemias [14]. The gene discussed is PPARA; the disease is metabolic syndrome.